Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
temsirolimus
temsirolimus
Brand names: Torisel
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 25 mg/mL |
Last updated: Jan. 9, 2024
- High Alert: CAUTION: See High-Alert Medication Policy
- Antineoplastic HD PPE and Disposal
- Antineoplastic HD Hazardous Drug Safe Handling Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. There is an exception for pediatric patients if use is necessary in the inpatient setting. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.
Safe Administration and Handling of Chemotherapy: See Policy 906.4802
Chemotherapy Preparation:
Preparation, Handling, Labeling, Dispensing and Disposal of Cytotoxic Drugs: Policy 916.4415
LH Pharmacy Services Chemotherapy Standards